Rosalind Elam, 65, loves visiting amusement parks with her friends and family.
Rosalind Elam
Long Island resident Rosalind Elam, 65, knew something wasn’t right when she began experiencing unusual headaches in March 2026. After two weeks with no improvement, she contacted her oncologist at NYU Langone Health’s Perlmutter Cancer Center. Further testing revealed high-grade serous carcinoma with leptomeningeal metastasis, a serious condition in which cancer spreads to the membranes surrounding the brain and spinal cord and into the fluid that protects them.
In April 2026, Elam enrolled in a four-week clinical trial combining an investigational medication with radiation to treat the cancer. She responded well to treatment and continues to receive care while maintain an active lifestyle, including riding roller coasters with her grandchildren, hiking, practicing yoga, and spending time with her friends.
When Unusual Headaches Led to a Diagnosis
A retired pharmacy technician who lives in Valley Stream, Long Island, Elam has been receiving care at NYU Langone for more than 20 years. She first met her oncologist, Alexander A. Hindenburg, MD, when she was diagnosed with breast cancer in 2006. More than a decade later, Dr. Hindenburg connected her with Alexandra Gewirtz, MD, a neuro-oncologist at NYU Langone, who helped diagnose and manage her condition.
“Dr. Hindenburg and I are close, and he understands me so well. When I told him about my headaches, he had me schedule an MRI as soon as possible and referred me to Dr. Gewirtz. I’m very grateful to him,” said Elam.
Leptomeningeal metastasis can cause serious neurological symptoms, including headaches, vision and hearing changes, difficulty swallowing, loss of bowel and bladder control, and weakness.
“It’s great that we were able to identify Rosalind’s diagnosis and start treating her right away,” said Dr. Gewirtz. “She was very smart and recognized that her headaches were unusual. It’s important for patients to understand their bodies so they know when something is off. Seeking care early can make a huge difference.”
Clinical Trial Offers New Treatment Option
Elam decided to enroll in a clinical trial led by Jonathan Yang, MD, PhD, a radiation oncologist and co-director of the Brain and Spine Tumor Center at Perlmutter Cancer Center. The four-week trial evaluated azeliragon, an investigational medication, in combination with radiation to the brain and spine for patients with leptomeningeal metastasis. Participants continue to undergo regular monitoring, including MRI scans of the brain and spine and tests of the fluid surrounding the brain and spinal cord, to assess their response to treatment.
Elam recalled, “I was apprehensive about the clinical trial at first. I had a lot of questions. But Dr. Hindenburg encouraged me and gave me the strength to do it. He said, ‘Let them treat you.’”
Since the beginning of the trial in April 2026, the number of cancer cells detected in Elam’s cerebrospinal fluid has decreased significantly, according to her care team. Although radiation sometimes left her feeling tired, she did not experience severe side effects during the trial.
“The clinical trial process was great. I felt how invested the staff members and care team were in my well-being. They asked me for feedback throughout the process–about how I was feeling, whether I felt like the drug was right for me, and whether I felt like I was in the right program. It was very reassuring,” she said.
Elam continues to receive treatment to manage her cancer and prevent further growth of cancer cell. She now receives Enhertu, a chemotherapy medication also used to treat certain types of breast cancer, every 3 weeks.
Living Fully and Supporting Others
Elam now encourages friends and fellow patients to take an active role in their care by asking questions and learning about their options.
“It was lovely to meet my fellow patients during the trial. I have other friends who have gotten surgery or needed medical care too. I tell them all to do research, ask about alternative treatment options that are available, and write down your questions,” said Elam. “I’m also a huge reader. The pamphlets and materials they give you at appointments or that are in the lobby contain a lot of tips for eating healthy, maintaining a social life, and finding community.”
“We are so thankful that this treatment was effective for Rosalind, and her story gives us hope for current and future patients with similar diagnoses,” said Dr. Yang.
About NYU Langone Health
NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 122 comprehensive academic medical centers across the nation five years in a row, and it continues to have the most No. 1– and top 10–ranked specialties among medical centers in the United States, according to U.S. News & World Report. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 400 outpatient locations in the New York City area and Florida. The system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.
Media Contact
Casey Nicholl
646-983-4920
Casey.Nicholl@NYULangone.org